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LETTERS TO THE EDITORRegarding “Endovascular vs open repair for ruptured
abdominal aortic aneurysm”
To paraphrase the conclusion of the recent paper by Nedeau et
al, they boldly state that “Given the mounting evidence for survival
advantage of rEVAR, RCTs of ruptured AAA may be unnecessary.
Thus, we recommend rEVAR as the standard of care,”1 which
reminds us of Horton’s painful caveat toward surgical research.2
Of note, the above notion was based on a retrospective analysis of
notmore than 74 patients (only 26% received ruptured endovascular
aneurysm repair [rEVAR]), whereas the authors suggested to ignore
conﬂicting randomized evidence because of its ‘small sample size.’1
What is this ‘mounting evidence’ of rEVAR superiority apart
from selective observations? First, the alleged mounting evidence
is the conclusion by analogy with elective aortic repair, where
EVAR reduced operative mortality signiﬁcantly in randomized
trials. What is easily forgotten, however, is that this applies only to
aneurysms suitable for EVAR. For ruptured aneurysms at least,
endovascular suitability was shown to be a strong predictor of
outcome,which is independent of the actual type of repair3 implying
relevant patient selection bias across nonrandomized series.4
Second, the alleged mounting evidence is the synopsis of
meta-analyses of open and endovascular ruptured abdominal aortic
aneurysm (rAAA) repair, respectively. Admittedly, these data seem
to demonstrate that perioperative mortality could be halved by use
of rEVAR (40% vs 20%).3 However, such a comparison essentially
means comparing the results of highly specialized centers of excel-
lence, treating carefully selected patients with the results of the
average vascular emergency service, which is left with increasingly
complex patients (eg, juxtarenal rAAA).
Unfortunately, results of open rAAA repair that do not ﬁt into
this ‘mounting evidence’ are easily ignored. For instance,we have re-
ported the surgical outcomes of 248 patients with rAAA over the
same period as the present study. Overall surgical 30-day mortality
was as low as 15.3%, although this consecutive series included all
comers including those with juxta- and suprarenal aneurysms, and
almost all underwent open repair (97%).3 Even among octogenar-
ians, surgical mortality was at 27% and, thus, below the reported
mortality of the entire present series, which was at 41% (30/74).1,5
Should we conclude that open repair be recommended for
every rAAA? Certainly not. Such a recommendation would be as
baseless as the above. rEVAR is an excellent option for properly
selected patients and centers. The point is the alleged ‘mounting
evidence’ is far from consistent.
Properly designed and powered randomized controlled trials
are needed more than ever because in the absence of compelling
evidence, costs associated with provision of around-the-clock
emergency endovascular infrastructure and expertise are difﬁcult
to justify. Moreover, many patients will continue to need open
repair (even in the current study, more than 53% of rAAA were
treated by open repair after introduction of the endovascular
protocol); therefore, open surgical competence must not be lost.
If anything, there is mounting evidence that similar results can
be reached by any method of repair if performed competently. To
improve overall results, comprehensive emergency management
should focus on an effective rescue chain, adequate imaging, proper
patient selection, delayed volume resuscitation, and fast control of
aortic bleeding.3 For this will beneﬁt all patients, and not only
a selected subset, aswill adequate surgicaland endovascular training.
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Reply
We recommend an “EVAR-ﬁrst approach” as the new stan-
dard of care in the treatment of ruptured abdominal aortic aneu-
rysms (rAAA) as outlined in our article “Endovascular vs open
repair for ruptured abdominal aortic aneurysm.” A multidisci-
plinary protocol, with endovascular surgical staff and equipment
availability is emphasized, to reduce perioperative mortality which
was 15.7% and 49% for ruptured endovascular aneurysm repair
(rEVAR) and open surgical repair (OSR), respectively. Overall
rAAA mortality, regardless of repair type, was 54% pre-EVAR
and 27% in the post-EVAR era. We found similar mortality
changes over time with administrative data from the Nationwide
Inpatient Sample database in which overall ruptured AAA repair
mortality decreased from 44.3% pre-EVAR to 39.9% post-EVAR
(open repair, 44.3%; EVAR, 32.4%) and more recently with Medi-
care data (overall mortality 44% in 1995 to 36% in 2008).1,2 We
recognize that our data are observational, yet our institutional
data are similar to a large number of single-center, multicenter,
nationwide database studies and meta-analyses that report similar
beneﬁt of rEVAR over OSR. As we discussed in the article, the
randomized controlled trial published by Hinchliffe et al3 found
similar mortality for rEVAR (53%) and OSR (53%). However,
there was signiﬁcant patient crossover from the rEVAR to the
OSR group, with intention-to-treat analysis. More than two-
thirds of the patients were excluded from the study because of
hemodynamic instability or staff unavailability.
We agree with Dr Dick and colleagues that EVAR suitability
would be expected to improve outcomes with rAAA repair, just
as elective open infrarenal AAA repair patients do better than
suprarenal. However, patients with infrarenal AAA undergoing
EVAR do better than with open surgery. This simply points out
that power calculations for randomized studies may have underes-
timated the number of subjects needed to show a difference.
We commend them on their excellent results. However, it is
possible that they may be able to improve their results even further
with a policy of using EVAR for ruptures. It may take longer to897
